Recombinant Human Erythropoietin (rHuEPO) Injection 2000 IU, 4000 IU, and 10,000 IU

Vaccine Overview

This injectable medication is used to treat anemia, particularly in chronic kidney disease, cancer patients undergoing chemotherapy, and surgical patients. rHuEPO stimulates red blood cell production by mimicking natural erythropoietin. Available in various strengths (2000, 4000, 10,000 IU), dosage depends on patient condition and response. Administered subcutaneously or intravenously, it improves hemoglobin levels, reduces the need for transfusions, and enhances quality of life in affected patients.

Drug Class: Recombinant and other Products

Indication: Treatment of anemia caused by chronic kidney disease (CKD), chemotherapy-induced anemia, and anemia related to certain surgical procedures.

PREVENTS

Anemia (CKD, cancer, surgery-related)

Vaccine Details

Applied To

Infants, Children, Adolescents, Adults

Recommended Time

As prescribed during treatment

Administration

Route: Subcutaneous (SC) or Intravenous (IV)

Site: Upper arm, abdomen, or thigh (SC); vein (IV)

Disease

Anemia (CKD, cancer, surgery-related)

Manufacturer

Serum Intitute Of India

Age

All age groups

Disclaimer

This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.

Last updated: May 2, 2025